21.07.2005

Health Canada recently reviewed available data for Baycox (Toltrazuril) that has been in use in Canada since 1992 to treat a parasitic infection in newborn piglets. Health Canada scientists concluded that, based on the data provided, they could not rule out the potential for Baycox to cause cancer in humans. After the filing of the Investigational New Drug Submission, Health Canada undertook a thorough review of the scientific data relating to the safety and efficacy of Baycox. At the conclusion of this review, Health Canada determined that the risks associated with the use of Baycox outweigh the benefits. Baycox is not approved for use in the United States. Baycox has been approved, however, for use in the European Union and Australia (Health Canada) .Toltrazuril is indicated also for treatment of coccidiosis in chicken and turkeys.